Ticker
LUNGCompany Name
PULMONX CORPSector
HealthcareIndustry
Medical DevicesExchange
NASDAQDate | Total Assets | Cash and Equivalents | Cash to Assets Ratio |
---|---|---|---|
6/30/2025 | $ 147.19M | $ 75.72M | 51.45% |
3/31/2025 | $ 150.74M | $ 74.81M | 49.63% |
12/31/2024 | $ 162.85M | $ 71.16M | 43.7% |
9/30/2024 | $ 167.4M | $ 63.57M | 37.97% |
6/30/2024 | $ 172.63M | $ 63.72M | 36.91% |
3/31/2024 | $ 164.58M | $ 70.39M | 42.77% |
12/31/2023 | $ 177.78M | $ 83.78M | 47.13% |
9/30/2023 | $ 185.02M | $ 95.18M | 51.44% |
6/30/2023 | $ 193.11M | $ 102.05M | 52.84% |
3/31/2023 | $ 201.27M | $ 110.64M | 54.97% |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
CashnEq / Assets
(=) Cash to Assets
Cash to Assets for PULMONX CORP is calculated as follows: CashnEq [ $ 40.04M ] / Assets [ $ 71.24M ]
(=) Cash to Assets [ 56.2% ]
Minimum
Jun 30, 2024
Maximum
Dec 31, 2020
Average
Median
filtered constituents | 3.94K |
---|---|
min | 0% |
max | 40.76% |
average | 9.78% |
median | 6.42% |
std | 9.53% |